Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The gap from .52 yesterday to today never filled either
Whats yer point?
From the seekingalpha article
On July 16, 2020, Relief Therapeutics and NeuroRx announced that the Data Monitoring Committee conducted a planned review of the first 30 patients treated in the Phase II/III Fast Track trial (Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure (COVID-AIV)). Per the release:
The committee determined that the study appeared capable of reaching a statistically significant endpoint within its 144 patient sample size and voted for the study to continue until its next scheduled evaluation in four weeks.
This appears to be a tremendous vote of confidence from the Data Monitoring Committee. Not only did they recommend that the study continue, after only 30 patients they determined that statistical significance appears to be reachable within the 144 patients in the trial. According to Relief Therapeutics and NeuroRx, "[the] Data Monitoring Committee determined that so far RLF-100 has generated no drug-related Serious Adverse Events or other safety concerns that would mandate stopping."
Of note, the Data Monitoring Committee is composed of the following individuals: 1. Professor Alfred Sommer, MD, MHS, Dean Emeritus of the Johns Hopkins Bloomberg School of Public Health; 2. Professor Rita Colwell, PhD, former Director of the National Science Foundation; and 3. Congressman Andy Harris, MD, MHS (MD District 1), also part-time Professor of Anesthesia and Critical Care at Johns Hopkins School of Medicine.
Coming Data Points
Based upon the companies' July 16 release, the DMC will evaluate the patient data in the Phase II/III Critical patient study again "in four weeks," which puts the next possible data release on about August 13, Thursday of this week.
What a load of crap.
This stock has not even started its run yet. Wait till the committee meets. chance of good news is extremely high.
Why isnt everyone screaming about Gap Down's always fill?
We closed in the 50's yesterday.
Yup. Quite simple. Don't fall for BS, hold your shares because you know they are worth a lot, the price goes up.
The boys had a good idea but their time is limited. Vaccine trials and therapeutic trials are fast gaining traction. There are plenty of traditional PPE suppliers and once the virus is under control guardstruments and its clone will vanish.
The question remains do the boys have enough class to share their success with the shareholders? Or are they complete PRICKS that I suspect them to be. Time will tell. but I am currently betting on them being PRICKS.
Please forward this post to ALL of them ASAP.
mods are being a lot nicer than I would. I would nuke every post that mentioned it.
Because it is off topic.
Aviptadil is the only fast track covid19 drug. Does that make it ok to talk about it on all covid 19 stock boards? No it doesn't.
This board is only for rlftf, not Putin Russian bullshit.
Again, mods remove this and all posts like it. This is not the RVV* board, or the remidis* board, or the Russion vaccine board.
This is for discussing and providing DD for RLFTF, not talking about all things covid19.
How much are people being paid to advertise this stupid Russian vaccine which had not been thru phase 3 trials yet?
Why is this on topic for rlftf which is actually in phase 2/3 trials now? I am not investing in Russia.
As has been stated repeatedly by scientists including Fauci, vaccines might work 50% of the time. I doubt something that skipped phase 3 and was tested on less than 100 people will work that well.
There will always be a huge need for a very good therapeutic like Aviptadil.
Since we have a review meeting Thursday this stock could get wild and crazy
thanks for sharing
We are assuming this is the 6th week of nasdaq filing which should mean it is done.
So we are holding and hoping for news any time.
I have been off for 3 weeks and I love it. Bored some days but I still love it.
looks like it might actually end green. that would be awesome after this 3 ring circus day.
HAHA. Very good one.
You believe everything he says?
I agree with most, believing a damn thing from Russia or China seems like a very bad bet.
What we have very likely in Aviptadil is a drug you can take at the first onset of symptoms and in a day or 2 you feel fine. that's if the upcoming trials for the inhaled version pan out.
Worst case we have the IV version which so far has been stellar. If we can cut death rates and hospital stays way down then all things will be good.
no no. wait until 8:35, lol
no way man, I am going to jump up and down and buy some cheapies.
AKA, I made a bunch of shit up just so I could drive panic and buy back in lower for another flip
So this is a bad investment a since RLFTF might only cure this disease and have a lock on the patents for only 3 years?
So they might only make billions and billions in 3 years so it is a bad investment?
LMMFAO
What a silly concept.
My .17s want to see dollars.
If folks would stop profit taking here we would already be in the .80s
Mods have every obligation to delete other ticker posts on this board. it is off topic.
i see they did, thank you!
thats a lot of money!
the first 30-45 minutes of the market is normally crap. Can't judge anything by it.
Of course a vocal subset will be talking about gaps filling.
A simple google search will dispel that myth.
It is just a mental thing that self-fulfills if enough trade thinking that way. Other than that it is bogus.
In Arkansas in mid-May when most people thought the 1st wave was over we had about 59 hospitalized and 12 on a ventilator. Now we have 497 hosp/117 vent.
If this drug could be picked up at the first sign of sickness and keep the majority of people out of the hospital it is worth a LOT more than $2-$3 per share.
This drug can possibly change the entire economic course of the world, and that isn't an overstatement. Maybe it wont work on everyone but no drug ever does. But it is now the leading candidate. The price should soon reflect it.
I kept averaging up Friday, lol. Looking forward to the dollar plus days coming coming soon
I like it!
This has been explained multiple times. Stop posting misleading info.
Make sure you are looking at the correct trials. We have more than 1. The planned inhalation trial which is more recent targets less ill people.
The original trial targeted the severe cases.
Patients with Critical COVID-19 and respiratory failure, currently treated with high flow nasal oxygen, non-invasive ventilation or mechanical ventilation will be treated with Aviptadil
https://www.clinicaltrials.gov/ct2/show/NCT04311697
You know your stock is doing well when you start fielding these kinds of comments.
This point is moot. Trials have parameters so that the same subset is tested across all drugs.
The goal of the drug is to keep people from getting so severe.
Yet this abstract describes 6 people that were too sick to qualify for the trial and the results are outstanding.
Rapid Recovery from COVID-19 Respiratory Failure after treatment with Vasoactive Intestinal Peptide
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3665228
Make sure you are looking at the correct trials. We have more than 1. The planned inhalation trial which is more recent targets less ill people.
The original trial targeted the severe cases.
No shit. He pretty much did by wording it like that
That would not surprise me but it had not happened yet. That will push us into dollars
The current situation...
Of course there are big dog companies pouring over the available data. As many have pointed out, a good therapy for covid 19 is priceless.
A LOT of money will be thrown at them in an attempt to buy them out.
I don't think we are going to have to wait for the end of the study to make a ton of $ here.